2021 LUNGevity Early Detection Award

LUNGevity’s Early Detection Award for Lung Cancer Translational Research program supports the development of strategies for the early detection and/or diagnosis of lung cancer.

Applicants must:

• Hold a doctoral degree and faculty appointment with an academic institution, including research institutions that are not formally associated with a university
• Have completed a training fellowship

The project that will be funded in 2021 is expected to have a direct impact on the early detection and/or diagnosis of lung cancer or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or diagnosis of lung cancer.

The Early Detection Award may be for a maximum of $200,000-$300,000 per year over two years. Annual milestones must be met.

LUNGevity uses a two-step application process:

1. A letter of intent (LOI), with a brief overview of the proposed project and biographical information
2. A full application with an extended narrative about the project, as well as supporting information and documentation. (Because there are a limited number of awards, only a subset of applicants is invited to submit a full application after the LOI review is completed.)